If the question is SPR versus fluorescence for peptide binding, these four abstracts answer only the fluorescence side. None report surface plasmon resonance, so SPR chip immobilization, kinetic fits and surface artifacts cannot be compared here. As of 3 October 2026, papers first published 16 July–17 September 2026 show that light-up, quenching, wash-free peptide release and tryptophan shifts report occupancy, covalent modification or membrane contact—and that those signals can disagree with one another.
Immobilization and labeling: who is modified
Label placement is a design choice. He, Sato and Nishizawa built forced intercalation-induced light-up peptide (FiLuP) probes by inserting thiazole orange as an amino acid surrogate at four positions in the RRE-binding HIV-1 Rev 34–50 peptide. Among those probes, E47 gave the largest fluorescence increase on RRE binding: a 58-fold light-up and a bound-state fluorescence quantum yield of 0.31. Selectivity was comparable to an N-terminal rhodamine B-labelled Rev control, indicating that internal thiazole orange incorporation largely retained the inherent RRE preference of the Rev-derived sequence. That control is this set’s only direct test of whether a different label site changes recognition (He et al., RSC Adv., 14 Sep 2026).
No abstract immobilizes a peptide on an SPR sensor. Surfaces that do appear are membranes, monolayers and an autodisplayed antibody. Francis, Verma, Hans and Chaudhary examined cathelicidin-DM with molecular dynamics, air/aqueous surface pressure, liposome fluorescence, Langmuir monolayers and dye-release assays. Simulation placed the peptide at a water/cyclohexane interface; experiment gave a saturation surface pressure of ~10–11 mN/m. With a POPC/CHL bilayer the peptide unfolded extensively and showed only transient interactions; with POPE/POPG it bound through its N-terminus and remained bound. Lipid monolayer critical insertion pressures were ~33.2 mN/m for POPC/CHL (10:1) and ~46.7 mN/m for POPE/POPG (7:3). Tryptophan fluorescence assays further indicated preferential binding to negatively charged membranes (Francis et al., Arch. Biochem. Biophys., 16 Jul 2026).
Sung and colleagues screened RNase A-binding Fv-antibodies from an autodisplayed library and used switching peptides as the fluorescent reporter. Release of the switching peptide upon RNase A binding enabled direct, wash-free fluorescence detection with a detection limit of 18.1 pg mL-1. Here the mobile label is a peptide that leaves the complex, not a fluorophore fixed on the analyte (Sung et al., Chem. Commun., 17 Sep 2026).
Chang and co-workers used fluorescence as a structural reporter of covalent chemistry, not as a reversible binding isotherm. Small molecular weight walnut peptides (S-WP) showed higher phenolic acid binding ratios and more pronounced losses of free amino and sulfhydryl groups, suggesting a greater propensity to form covalent conjugates. Conjugation reduced peptide surface hydrophobicity, enhanced ultraviolet absorption, induced fluorescence quenching and increased random coil content (Chang et al., Food Chem., 10 Sep 2026).
Kinetics, apparent affinity and artifacts that a second channel must catch
Only the Rev-derived E47 probe comes with a titration-derived affinity: an apparent Kd of 0.84 ± 0.70 nM under the conditions employed. The uncertainty interval is comparable to the point estimate, so the number should not be treated as a precise thermodynamic constant. The fluorescence response to RRE RNA was more than 2-fold that of tested non-cognate model RNAs. E47 also worked as an indicator in a fluorescence indicator displacement assay and supported concentration-dependent detection of an RRE RNA model with limits of detection of 190 pM in buffer and 220 pM in 10% serum. Serum tests matrix interference; association and dissociation rate constants are not reported (He et al.).
The cathelicidin-DM data show why a binding fluorescence channel is not a functional readout. Preferential binding to negatively charged membranes by tryptophan fluorescence did not predict lysis: the peptide preferentially perturbed zwitterionic vesicles and spared the negatively charged ones. The authors note that antimicrobial peptides often act cooperatively, so tight binding could reduce cooperativity and impair activity. Dye release and tryptophan shift therefore need each other even before any other biophysical method is added (Francis et al.).
Quenching after phenolic acid conjugation tracked covalent modification and accompanied higher antioxidant activity that correlated with phenolic acid content. Reading that quench as reversible occupancy would confuse adduct formation with an equilibrium binding curve (Chang et al.). The RNase A format is wash-free by construction, which avoids wash steps that can remove weak complexes, but the abstract reports a detection limit rather than kinetic constants or a broad nonspecific-protein panel (Sung et al.).
Match the research question, then pick an orthogonal test
| Research question | Fluorescence design in this set | Principal artifact or limit | Orthogonal confirmation still needed |
|---|---|---|---|
| Occupancy of cognate RNA by a peptide probe | Internal thiazole orange light-up versus N-terminal rhodamine B control | Apparent Kd with large uncertainty; selectivity only >2-fold versus tested non-cognate RNAs | An independent affinity method; SPR is not reported here |
| Direct, wash-free detection | Switching-peptide release from an Fv-antibody | Detection limit only; no kinetic constants | A specificity panel; label-free confirmation is absent from these abstracts |
| Covalent peptide–phenol conjugation | Intrinsic fluorescence quenching plus amino/sulfhydryl loss | Quenching reports chemistry and structure, not reversible Kd | Compositional stoichiometry already implied by group-loss data |
| Peptide–membrane contact versus lysis | Tryptophan binding versus dye release, plus monolayers and simulation | Binding preference did not match perturbation preference | Do not substitute one fluorescence channel for the other |
What can be concluded from this set is limited: fluorescence can rank occupancy, report covalent adducts, or flag membrane contact, but the photophysical event is not interchangeable with activity or with a label-free kinetic constant. One remaining question is whether a label-free surface kinetic experiment would have ranked cathelicidin-DM’s residence on anionic versus zwitterionic membranes the same way tryptophan fluorescence did, or whether a different surface would have produced a different nonspecific background than liposomes or 10% serum. That SPR-versus-fluorescence comparison is exactly what this evidence set cannot close.
Checklist before treating a fluorescence number as peptide binding:
- Name the photophysical event (light-up, quenching, tryptophan shift, or displaced switching peptide).
- State which molecule is labelled and at which position, or whether the fluorophore is intrinsic.
- Record covalent versus reversible chemistry.
- Keep any apparent Kd together with its reported uncertainty and the conditions-employed qualifier.
- Pair a binding channel with a functional or compositional readout when the question is activity, not occupancy.
- Do not import SPR immobilization or kinetic parameters unless an SPR experiment is actually reported.
Frequently Asked Questions
Do these papers compare SPR and fluorescence head-to-head?
No. None of the four retrieved abstracts report surface plasmon resonance, so SPR immobilization and kinetic parameters cannot be compared from this evidence set.
What affinity did fluorescence titration give for the Rev-derived E47 probe?
Fluorescence titration afforded an apparent Kd of 0.84 ± 0.70 nM under the conditions employed, with a 58-fold light-up on RRE binding.
Can tryptophan-reported membrane binding be read as lytic activity?
Not in the cathelicidin-DM study: tryptophan fluorescence indicated preferential binding to negatively charged membranes, but the peptide preferentially perturbed zwitterionic vesicles and spared negatively charged ones.
Explore Further
Browse our research peptide catalog and review third-party lab reports & COAs for published batches.
---
Research use only. The information above is provided for educational and laboratory research purposes only. The compounds discussed are not approved for human or veterinary use, diagnosis, treatment, or the prevention of any disease. Nothing here is medical advice.